Boston Biomedical Innovation Center

What Boston Biomedical Innovation Center does

Boston Biomedical Innovation Center (B-BIC) is a privately held life-sciences accelerator founded in 2013 and headquartered in Cambridge, Massachusetts. Its stated purpose is to accelerate innovation and translational research in healthcare — functioning as an intermediary that channels funding, expertise, and industry contacts to academic investigators and early-stage biomedical projects, most plausibly within the Harvard/MIT/Mass General Brigham ecosystem in the greater Boston area. The organization's leadership comprises three named directors: Roger Kitterman as Executive Director, Rachel Napear as Director of Communications, Public Relations and Marketing, and Lesley Watts as Director of Operations and Finance, consistent with the operating footprint of a small non-profit accelerator.

B-BIC operates with a 1–10 employee footprint and does not disclose a product, technology platform, or proprietary pipeline in the available source material; the organization's website (b-bic.org) was blocked by bot verification and yielded no substantive content on programs, portfolio companies, or services. There is no disclosed pricing model, customer roster, partnership roster, certification, patent, or award in the input data. The organization's business model is therefore not directly verifiable from the source, but as a translational-research accelerator, plausible revenue mechanisms include NIH/NCATS pilot grants, institutional or university funding, and corporate sponsorship — none of which are itemized here.

The data set carries material gaps: no funding rounds, revenue figures, customer references, strategic partnerships, regulatory actions, or product launches are documented. The only firmographic anchors are the founding year (2013), location (Cambridge, MA, United States), and the three-person executive team. As a result, any analytical output on B-BIC is necessarily constrained by the absence of first-party disclosure; downstream assessments of growth, moat, and revenue should be treated as preliminary and re-validated as the organization's underlying operating data becomes accessible.

Name

Boston Biomedical Innovation Center

Website

https://b-bic.org

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Cambridge

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Core offering

Boston Biomedical Innovation Center (B-BIC) is a life sciences accelerator that supports the development and commercialization of biomedical innovations. It provides resources, programs, and translational research assistance aimed at advancing healthcare research from early-stage concepts toward clinical and commercial outcomes.

Differentiator

Problem solved

Functional benefit

Products and services

• Life Sciences Acceleration Program

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Expansion highlights2 records

Direct peers

• JLABS (Johnson & Johnson Innovation): Global network of life sciences incubators operated by J&J Innovation offering lab space, mentorship, and programming for biotech startups. Highly comparable as a healthcare-focused accelerator supporting translational innovation.
• LabCentral: Cambridge, MA-based biotech incubator providing lab space and programming for early-stage life sciences startups. Direct comparable as a Cambridge-based biomedical innovation hub serving translational researchers and emerging biotech companies.
• MBC BioLabs: Bay Area-based biotech incubator offering turnkey lab space and programming for early-stage life sciences companies. Comparable mission of accelerating biomedical innovation and translational research through shared infrastructure.

Peers

• Alexandria LaunchLabs:

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/bbic_ncai

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Boston Biomedical Innovation Center